32 results
Thumbnail

D1.64 - Distinct and Overlapping Sensitization Patterns to Crustacean and House Dust Mite Allergens in Tropical Allergy

Thumbnail

D1.72 - Assessing potential influencing factors on allergic reaction to the cumulative dose given on an extra day within oral food challenge in food-allergic children

Thumbnail

D1.75 - Association of SCORAD Values with Skin Barrier Function Indicators in Patients with Atopic Dermatitis

Thumbnail

D1.61 - Shrimp Tropomyosin as a Selective Allergen in a Case of Food Allergy: The Value of Individualized Molecular Analysis

Thumbnail

D1.62 - Thermal stress alters the allergen and proteome profile of the redclaw crayfish (Cherax quadicarinatus)

Thumbnail

D1.63 - Suspected Hypersensitivity to Non-Nutritive Sweeteners With Recurrent Respiratory Manifestations in a Pediatric Patient

Thumbnail

D1.65 - Selective Allergy to Large Prawn: Identification of a Projectin-Derived IgE-Binding Protein

Thumbnail

D1.66 - Allergy profiling in selective goat and sheep milk allergy

Thumbnail

D1.67 - Comparison of machine learning models for grass carp allergy diagnosis

Thumbnail

D1.70 - IgE-sensitization to allergens in plant-based drinks in children with cow’s milk allergy

Thumbnail

D1.71 - Can an allergist predict the development of allergies? A Clinical case of dizygotic twins with divergent outcomes

Thumbnail

D1.73 - Date Palm or Grass pollen rhinoconjuctivitis in a patient with watermelon allergy?

Thumbnail

D1.74 - Sunflower Seed–Induced Anaphylaxis: Allergenic Characterization and Evidence of Cross-Reactivity with Niger Seeds

Thumbnail

D1.105 - Real-Life Evidence of Type 2 Immunomodulation with Benralizumab: From Steroid-Dependent to Controlled Asthma

Thumbnail

D1.106 - Dupilumab-Induced Systemic Eosinophilic Immune Activation Mimicking an EGPA-Like Prodrome: A Case Report

Thumbnail

D1.108 - Optimization of phenotyping in severe T2-bronchial asthma

Thumbnail

D1.109 - Biologics selection algorithm for severe T2-bronchial asthma targeted therapy

Thumbnail

D1.110 - Long Term Mepolizumab in Type-2 CRSwNP: Marked Polyp Reduction, Symptom Relief, and Airway Benefits in Real World Comorbid Patients

Thumbnail

D1.111 - Tezepelumab reduces in patients with severe allergic asthma and rhinoconjunctivitis not only bronchial but also nasal and conjunctival symptoms – results from an exposure chamber study

Thumbnail

D1.112 - ILC2 Expansion as a Biomarker of Suboptimal Response to Dupilumab in Severe Asthma: Findings from the PRISM Study